Center-Authored Papers

Filters: Author is Faca, Vitor M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Up-Regulation
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
Tumor Microenvironment
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Tumor Markers, Biological
Hanash SM, Pitteri SJ, Faca VM.  2008.  Mining the plasma proteome for cancer biomarkers.. Nature. 452(7187):571-9. Abstract
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Transforming Growth Factor beta
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Tandem Mass Spectrometry
Zhang Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, DePinho RA, Bardeesy N, Dinulescu D et al..  2008.  A mouse plasma peptide atlas as a resource for disease proteomics.. Genome biology. 9(6):R93. Abstract
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Surface Plasmon Resonance
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract
Specimen Processing Core Facility
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Signal Transduction
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Shared Resources
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
September 2011
Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash SM, Agus DB, McIntosh MW, Mallick P.  2011.  Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.. PloS one. 6(7):e23090. Abstract
Sensitivity and Specificity
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract
RNA, Messenger
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Reproducibility of Results
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract
Public Health Sciences Division
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash SM, Agus DB, McIntosh MW, Mallick P.  2011.  Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.. PloS one. 6(7):e23090. Abstract
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Kani K, Faca VM, Hughes LD, Zhang W, Fang Q, Shahbaba B, Luethy R, Erde J, Schmidt J, Pitteri SJ et al..  2012.  Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition.. Molecular cancer therapeutics. 11(5):1071-81. Abstract
Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G et al..  2009.  Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.. Molecular & cellular proteomics : MCP. 8(3):451-66. Abstract
Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S.  2009.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.. Biosensors & bioelectronics. 24(7):2143-8. Abstract